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Changing practice: assessing attitudes toward a
NICE-informed collaborative treatment pathway
for bipolar disorder
Adele Louise Elliott, Stuart Watson, Guy Dodgson, Esther Cohen-Tovée and Jonathan Ling
Background
Bipolar disorder is a chronic mental health condition, which can
result in functional impairment despite medication. A large evi-
dence base supports use of psychological therapies and struc-
tured care in the treatment of mood disorders, but these are
rarely implemented. e-Pathways are digital structures that
inform and record patient progress through a healthcare system,
although these have not yet been used for bipolar disorder.
Aims
To assess the perceived benefits and costs associated with
implementing a collaborative NICE-informed e-pathway for
bipolar disorder.
Method
Healthcare professionals and people with bipolar disorder
attended a workshop to share feedback on e-pathways. Data
were collected through questionnaires (n = 26) and transcription
of a focus group, analysed qualitatively by a framework analysis.
Results
Patients and healthcare professionals welcomed the develop-
ment of an e-pathway for bipolar disorder. There were five ele-
ments to the framework: quality and delivery of care, patient–
clinician collaboration, flexibility and adaptability, impact on staff
and impact on healthcare services.
Conclusions
Identification of benefits and costs ensures that future develop-
ment of e-pathways addresses concerns of healthcare profes-
sionals and people with bipolar disorder, which would be
essential for successful implementation. Recommendations for
this development include making e-pathways less complicated
for patients, ensuring sufficient training and ensuring clinicians
do not feel their skills become invalidated. Limitations of the
study, and directions for future research, are discussed.
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Bipolar affective disorder
Bipolar affective disorder has a lifetime prevalence of between 1 and
2.5% of the population.1,2 It is diagnosed on the basis of current or
prior manic or hypomanic episode(s);3 however, low mood that is
frequently persistent4 and can meet criteria for a depressive
episode is more common.5,6 The disorder is further characterised
by functional impairment7 and increased mortality rates,
including from suicide.8 The estimated cost to the UK is £5.2
billion annually, with direct National Health Service (NHS) costs
of £342 million.9,10 Biological, psychological and social treatment
paradigms are used,11 and treatment pathways differ between
patients in depressed versus manic episodes, and in patients who
are between episodes.12 Pharmacological interventions reduce
relapse and treat episodes, if used appropriately12 Similarly,
psychological interventions specifically developed for adults with
bipolar disorder improve symptoms and prevent relapse and admis-
sion to hospital.13,14 These interventions include enhanced relapse
prevention, group or individual psychoeducation,15–17 cognitive–
behavioural therapy and family-focussed therapy.18 Group psy-
choeducation arguably has the strongest evidence base. Research
over the past 15 years has concentrated on resource light strategies,
with groups integrated within existing treatment pathways
(e.g.19,20). However, these evidence-based treatments are not
widely available within the NHS.
Care pathways
Care pathways represent a formalisation of the process that under-
lies care and usually incorporate one or more protocols and
guidelines, provide a record of care and a variance record to
show where deviations from the planned pathway have occurred.21
Computerisation, thereby creating e-pathways, should allow
pathways to be integrated with guideline-based decision support,
the electronic health record and the clinical workflow.22 The
entry point to an e-pathway is through an initial care plan. The
patient engages in the development of a formulation and
the only outcome measure is CollaboRATE, a rating scale for
patients that measures how involved they feel in their care.
The e-pathways would be accessible to patients, both in the
session and accessible through the Cumbria, Northumberland,
Tyne and Wear NHS Foundation Trust website, therefore
encouraging individuals to be aware of, and request, evidence-
based care. The treatment strategies suggested by the e-pathway
would be delivered as part of a collaborative care plan.
e-Pathways therefore have the potential to improve access to,
and use of, the current evidence base and guidelines, to embed
values of co-production by building a shared understanding of
the difficulties faced by people with bipolar disorder, and to
allow formal evaluation of deviations. e-Pathways thus enable
identification of resource gaps, training needs and guideline
weaknesses. Our NHS mental health trust has an expressed
commitment to develop a series of e-pathways that incorporate
clinical algorithms. e-Pathways require collaboration between
our NHS trust and the electronic patient record provider, and is
still under development for bipolar disorder. A pilot showed that
the original proposed software package was too time-consuming
for clinicians to use. The focus is now shifting to examine
options to develop the e-pathway, using the existing capabilities
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of the electronic patient record supported by a bespoke trust-led
software package.
Algorithm based care
Algorithm-based care refers to the use of clinical algorithms either
to aid diagnosis or treatment. Clinical algorithms often comprise
step-by-step instructions, often presented in flow-chart form, to
guide the clinician.23 Studies of unipolar depression have revealed
that the use of algorithms markedly improves outcome.24,25 In
bipolar disorder, the Texas Medication Algorithm Project26 has
revealed feasibility and efficacy in a public health setting. This has
been replicated in a Brazilian study.27 Our model incorporates the
concurrent use of three algorithms, biological, social and psycho-
logical, with different algorithms for patients who are currently in
a depressive episode; in a manic, hypomanic or mixed episode;
and out of episode (yielding a total of nine algorithms). The algo-
rithms are being produced iteratively, and are based on National
Institute for Health and Care Excellence (NICE) guidelines, with
support as needed from other clinical guidelines – notably that
produced by the British Association of Psychopharmacology12
and by the extant evidence base. An example algorithm is shown
in Fig. 1.
Practice change
The movement from the existing structure of care to an alternative
in which treatment decisions are made within a framework pro-
vided by algorithms, which, in turn, are incorporated into an
e-pathway, represents a significant change in practice within our
large organisation. Implementation of such a change requires
careful consideration.28 In healthcare, it has been argued that
allowing staff to define problems and formulate solutions facilitates
even those change processes that are initiated by managers.29 Here,
we therefore sought to explore the views of healthcare professionals
and people with bipolar disorder; specifically looking at the benefits
and costs that are relevant to the development and implementation
of an e-pathway for bipolar disorder, to steer and facilitate this
change.
Individual psychoeducation






















Fig. 1 Psychological pathway for out-of-episode bipolar disorder. Note: Entry onto the pathway is determined by a healthcare practitioner that
the patient has bipolar disorder and is currently not in episode. Green and red arrows demarcate ‘yes’ and ‘no’, respectively. A diamond box
indicates a decision, and rectangular boxes indicate an action. Behind each of these boxes is the necessary information to make a collaborative
decision or action, for example: behind ‘Positive screen for sleep disorder?’ there is a rationale for screening for sleep disorders, and a
description and screening tools for sleep apnoea and restless leg syndrome. If patients screen positive, the algorithm takes them to the
‘Resolved?’ decision box, where initial advice is given to address the sleep disorder. If this fails to resolve the situation, the algorithm takes the
patient and healthcare practitioner to ‘Refer to sleep clinic’, in which information is provided to inform the decision to refer to local clinic, and if
appropriate, a referral form. The algorithm next presents a choice of five options, and the information behind the boxes allows the healthcare
practitioner to action the choice, or to flag if the resource is not available, e.g. group psychoeducation. The individual can follow the flow chart,
e.g. starting with CBT-I and progressing with some individual psychoeducation delivered by the care coordinator, until the individual has
confidence to sign up to group psychoeducation. Once this is complete, the patient and healthcare practitionermay feel that psychoeducation or
sleep-work is not appropriate. If ‘Further psychological input needed?’ is answered ‘no’, the patient is discharged from the psychological
pathway, and continues on the biological and social pathways. An asterisk indicates that it is outside the scope of theNational Institute for Health
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Method
Study design and setting
Data collection took place in a single session, a day-long workshop
organised by the e-pathways team, to present the bipolar disorder
e-pathway for discussion.
Recruitment and participation
Various methods were used to invite healthcare professionals and
people with bipolar disorder to the workshop. The workshop was
advertised twice via the Trust’s weekly bulletin, which is sent to
all employees of the Trust. Individuals who had shown earlier inter-
est in the event from a previous bulletin were also directly invited,
and invitations were cascaded within the trust, such as via the
allied Health Professional Senior Leadership Team. Finally, an
open invitation was extended to a bipolar disorder patient/carer
group, and other individuals who had previously shown an interest
in e-pathways. A combination of open invites and targeted recruit-
ment ensured that feedback from the workshops spanned a variety
of occupations and provided a range of perspectives. In total,
28 people attended the workshop. Members of the e-pathway
team were also in attendance. Not all attendees provided their job
roles within the NHS Trust, although occupations of those in
attendance included clinical psychologists, peer-support workers,
student nurses, consultants and community psychiatric nurses.
Two employees of the NHS Trust in attendance also indicated
they had a diagnosis of bipolar disorder, allowing them to provide
further insight from the perspectives of healthcare professional
and patient. Finally, one person from the bipolar disorder support
group was in attendance, as was a carer for a family member with
bipolar disorder. In total, three participants had bipolar disorder.
Format of the workshop
The day included presentations from the bipolar e-pathways team,
including presentation of the algorithms that were on display
throughout the day, a presentation from a person with bipolar dis-
order within the Trust, and two focus groups, one of which gave
feedback on the pathway during a semi-structured group discussion
that incorporated open-ended questions, with prompting for
further elaboration. The second focus group explored the training
implications of the e-pathway; however, as this was not a focus of
the present study, no data were recorded from this group, although
all participants from this second focus group completed the ques-
tionnaire at the end of the workshop. Attendees had free choice of
breakout group. Two of the participants with bipolar disorder
attended the focus group that was transcribed.
Data collection
Transcription of focus group
At the start of the discussion, those within the focus group were
made aware that the session was to be transcribed. Before beginning,
participants were reassured that their responses would remain
anonymous. Audio recording was not possible because of logistical
constraints. As such, the researcher transcribed the discussion by
hand. As much detail was gathered as possible, and where individual
fragments were missed, a summary of the speaker’s point was
instead made. The handwritten transcription was later transferred
to computer and checked for accuracy by the researcher.
Questionnaire
A questionnaire was designed before the workshop, to explore views
about the development of an e-pathway for bipolar disorder. All
respondents were made aware of the purpose of the questionnaire.
The questionnaire (see Table 1) was distributed and completed at
the end of the day. Following the session, responses were compiled
into a document for analysis
Data were analysed by framework analysis,30 to systematically
establish relationships within the data to answer relevant questions
through the generation of a framework. This method of analysis,
developed for applied policy research, is becoming increasingly
used within healthcare and medical research.31 It allows the flexibil-
ity to examine ideas that arise from the data during analysis.32
Themes can be described as concepts that aim to describe the
data.31 We followed the five stages to framework analysis: familiar-
isation, identification of a thematic framework, indexing, charting,
and mapping and interpretation.
Ethical approval
As a service evaluation, this study did not require consent to be
granted from Newcastle University nor NHS Research Ethical
Committees. However, all procedures contributing to this work
comply with the ethical standards of the relevant national and insti-
tutional committees on human experimentation and with the
Helsinki Declaration of 1975, as revised in 2008. Participants
acknowledged their consent to discuss the topic before participating
in group discussions.
Results
In total, 26 questionnaires were submitted at the end of the work-
shop. All respondents indicated that they welcomed the develop-
ment of the e-pathway for bipolar disorder. Through analysis of
the questionnaires and focus group, we developed an analytic
framework that comprised five key concepts: quality and delivery
of care, patient–clinician collaboration, flexibility and adaptability,
impact on staff and impact on healthcare services.
Quality and delivery of care
Participants were asked how they felt the quality of care, and
care delivery, would be affected as a result of implementation of
e-pathways. Overall, healthcare professionals and patients felt that
the implementation of an e-pathway for bipolar disorder would
improve care. A key theme was that the consistency of care would
improve, and that there would be a sense of equality of care.
Another benefit for the implementation of e-pathways was that it
was felt that clinicians would be more likely to deliver care concord-
ant with NICE guidelines, which would be associated with improved
outcomes for patients.
‘I’d hope it will create a more consistent baseline to good prac-
tice in offering evidence-based interventions whilst
Table 1 Bipolar e-pathway questionnaire
Question
1 How do you think an e-pathway for people with bipolar disorder will
affect the quality of care you/the Trust deliver/receive?
2 Would you welcome the development of such a pathway? What do you
see as the advantages?
3 Do you have any concerns about the pathway? Are there potential
negative consequences?
4 In what way do you think support, guidance and/or training could be
developed to improve the quality of care you deliver/receive?
5 Do you have any further comments about the Bipolar Pathway?
6 Would you be interested in helping to develop the pathway? If yes,
please give your contact details below
e‐Pathway for bipolar disorder
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understanding the subtleties of why sometimes we alter our
treatments’ (questionnaire, no role given).
Furthermore, a theme arose from the discussion that having stan-
dardised care and the ability to record treatment progress would
allow clinicians who regularly deviate from NICE guidelines,
without sufficient justification, to be ‘flagged’. This could assist
with highlighting areas where care is consistently substandard.
A further concept that arose was that e-pathways would be
expected to facilitate the development of evidence-based and
value-based treatment strategies. One healthcare professional
indicated:
‘I think it has enormous potential in improving the quality of
care of service users and helping staff in deciding/delivering
evidence-based practice’ (questionnaire, consultant clinical
psychologist).
Furthermore, another respondent felt that the e-pathway would
help to:
‘[i]mprove the consistency of approach – aligned to the evi-
dence base of what works [and] support recording of decision
making about treatment and variance from NICE recommen-
dations’ (questionnaire, psychologist).
Overall, following analysis, the idea that the quality and delivery of
care would improve was widespread; however, care must be taken to
ensure equality of availability of interventions.
Patient–clinician collaboration
The collaborative relationship between clinician and patient as a
result of e-pathways, including a more holistic approach to care,
increased co-production, and increased patient engagement also
emerged from the data. A presumed benefit of e-pathways would
be the ability to include the patient in the decision process of treat-
ment, as both clinician and patient could view the algorithm within
e-pathways, and discuss options relating to each stage or interven-
tion. Most questionnaire respondents raised the idea of increased
collaboration as a result of e-pathways, with many also indicating
they believed it would be a more holistic model of care.
‘It should improve quality outcomes and service user experi-
ence by ensuring informed decisions about elements of care
packages, ensuring consideration to be given to a holistic
bio-psycho-social approach […] better engagement with inter-
ventions and service due to collaborative transparent
approach’ (questionnaire, no role given).
However, a potential barrier arose in the physical appearance of the
algorithm:
‘Showing [a] patient the visual form would be overwhelming. I
feel overwhelmed looking at the flow chart. It could be easier to
follow or more friendly looking or I would not show it to a
patient’ (focus group, psychologist).
Therefore, consideration must be given to the appearance of the
decision-tree, or how it could be better presented to patients to
prevent this being a barrier.
The final element of collaboration related to family members or
carers, with one healthcare professional indicating e-pathways
would be:
‘[An] extra resource to utilise when working with clients and
their families’ (questionnaire, no role given).
e-Pathways were perceived as providing an effective way to main-
tain collaboration between the patient and those involved in their
care, including carers, family members and clinicians.
Flexibility and adaptability
Flexibility and adaptability refer to how e-pathways for bipolar dis-
order could change to provide optimal care. In relation to concerns
regarding implementation of e-pathways, one respondent indicated:
‘Possibility of being a little rigid but [a] clinician can utilise
[their] own clinical decision making to justify care and treat-
ment going forward in care plans, progress notes, etc.’ (ques-
tionnaire, community psychiatric nurse).
Participants emphasised the importance of ensuring that clinicians
were aware of the scope to use their own clinical judgement to
deviate from the treatment algorithm, with justification and to
adapt treatment to suit specific groups and to be flexible to accom-
modate management of other co-morbidities. One concern that
arose from several healthcare professionals related to individuals
with co-morbidities and adapting e-pathways to suit other groups,
such as adolescents or the elderly:
‘Need to ensure co-morbidities are understood and that people
don’t forget about problems that don’t fit under this diagnosis’
(questionnaire, no role given).
Healthcare professionals suggested that broadening the e-pathway
process to support both pre-engagement and recovery would be
important in improving care for patients with bipolar disorder.
For example, pre-engagement could include enabling the patient
to be able to access resources relating to the algorithms and/or inter-
ventions before commencing treatment.
‘If public-facing it could introduce the patient early for [their]
own research or mood diaries’ (focus group, consultant).
Similarly, healthcare professionals believed it would be beneficial if
e-pathways could be adapted to support both post-engagement
recovery.
Impact on staff
Respondents reported that they felt that the implementation of
e-pathways would have an impact on staff such as clinicians and
mental health nurses, and that clinicians would benefit from the
more structured guidance and clearer expectations, which may
increase clinician confidence.
‘I think a downstream advantage may be that clinicians come
to supervision with clearer expectations and questions e.g.
‘We got stuck doing X, how can I approach this with the
client?’, which would drive the quality of care’ (questionnaire,
psychologist).
‘[The] principle of an e-pathway which will guide clinicians is
excellent, having information and interventions/guides will
enhance confidence’ (questionnaire, consultant clinical
psychologist).
However, sufficient guidance was felt to be needed to ensure that
individuals were aware of their job role expectation with regard to
delivery of e-pathways:
‘There must be greater clarity re job role expectations – who is
expected to deliver what and how this fits within [the] broader
job role’ (questionnaire, psychologist).
One benefit that was identified was the idea of an aspirational
pathway, that e-pathways provided the standard of care that
should be aspired to, which could give staff a clearer sense of
purpose and boost morale. However, this could present a possible
barrier: some clinicians stated that they may feel frustration if
they are unable to deliver the recommended standard of care such
as through a lack of resources. One respondent indicated that this
Elliott et al
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could be ‘demoralising’ (focus group, practitioner adolescent ser-
vices). Another indicated:
‘[The] clinician may become overwhelmed if there are no staff
resources to develop care or do not have training to implement
certain groups or one to one session’ (questionnaire, no role
given).
This sense of an impact on staff was mirrored by a potential impact
on patients: disappointment if a recommended intervention was not
available in all areas. This was thought likely to be especially difficult
for individuals in rural areas, or those with limited mobility that are
unable to travel:
‘[The] risk of it being a “postcode lottery” – shows what should
be offered but if not available in that service [due to lack of
funding in a particular location]; it would be frustrating for
the service user’ (questionnaire, no role given).
A further cost stemmed from concerns regarding increased pressure
and demands on staff:
‘Support to engage with the pathway, staff feeling overwhelmed
and overloaded and pressured to discharge’ (questionnaire,
consultant clinical psychologist).
Although some indicated they felt implementation of e-pathways
could be time-saving and reduce their workload, others indicated
the pressures staff already faced could present an issue in terms
of uptake. A further factor that could affect staff is the idea of
‘process-driven care’. Several healthcare professionals voiced
concerns that e-pathways would become a ‘tick-box exercise’
(questionnaire, perinatal mental health team).
‘We need to ensure we are using it with purpose, not because
we have to’ (questionnaire, no role given).
One issue was that the implementation of e-pathways would
become a method of monitoring staff performance as opposed to
a tool to provide guidance and resources. One respondent on the
questionnaire indicated that, despite the stated purpose of e-path-
ways to provide support for and not to assess clinicians, they were
concerned that it may ‘become part of a performance framework’
(questionnaire, no role given).
Also, a key issue to implementation was the concern that it
‘takes the art out of nursing’ (questionnaire, no role given) or ‘[I]
worry that it might unwittingly invalidate care working skills’ (ques-
tionnaire, psychologist); namely, that it may lead to a loss of instinct
and clinical judgement.
Impact on healthcare services
This concept relates to how implementation of e-pathways would
affect healthcare services, with concerns relating to cost, training
and resources.
‘My underlying concern is how it would be implemented,
resources, staff, training […] and being put into practice’
(focus group, practitioner adolescent services).
One key benefit raised was that implementation of a system such as
e-pathways would facilitate the auditing process:
‘Agree it may help to highlight gaps in resources and help us
think about how to tackle this’ (questionnaire, no role given).
For example, if the treatment algorithm regularly recommends
an intervention that is not available in one locality, it is easier to
identify where care or resources are falling short.
A barrier with a potential to affect the implementation of
e-pathways was training, with many healthcare professionals
indicating the necessity of sufficient training to ensure correct
implementation and use of e-pathways:
‘Need to establish [the] training needs of staff of different pro-
fessions and peer support workers and experts by experience.
Some of this will be awareness and care skills, some related
to specific interventions’ (questionnaire, no role given).
A specific concern related to training around interventions, as many
believed there were currently insufficient practitioners trained in the
interventions that would be recommended within the treatment
algorithm. This relates to similar concerns regarding availability
of resources. A further concern related to insufficient supervision
being in place to support training and implementation.
Discussion
Overall, healthcare professionals and patients welcomed the develop-
ment of the e-pathway for bipolar disorder, and helped to define
several benefits supporting the implementation of e-pathways, includ-
ing improvements in the quality and consistency of care, increase in
good practice and NICE-concordant care, clearer guidelines resulting
in increased satisfaction for clinicians, a more collaborative approach
to care and ability to monitor care and resources. If e-pathways are to
be successful, the benefits identified by patients must remain central to
development and implementation. However, it is arguably of at least
equal importance to establish the barriers that could hinder imple-
mentation in order for necessary solutions to be developed. Costs
and possible recommendations are discussed below.
In keeping with previous research,33 healthcare professionals
feared loss or invalidation of care skills, clinical instinct and confi-
dence in unsupported clinical decision-making by trainees. The
potential liability consequent on deviations from the algorithm
was also a concern. This highlights the importance for the
pathway team of adequately communicating that the standard of
care recommended in e-pathways is aspirational, and that health-
care professionals should feel able to use clinical judgement and
deviate from the algorithm. This further emphasises the importance
of collaborative algorithm development.
The algorithm was seen as ‘overwhelming’ for healthcare prac-
titioners and patients because of its apparent complexity. A further
concern was that irrelevant aspects of the treatment algorithm
would still be visible for some patients, such as the inclusion of med-
ications that could be contraindicated. One individual suggested
that a more user-friendly version, such as a simplified paper
handout, could be developed. A further suggestion was that a
‘step’ within the algorithm could change colour to indicate when
it is completed, to make the visual aspect of the flow, charts more
intuitive and easier to follow from a patient perspective. These
recommendations need to be considered in the e-pathway design
and a combined approach may be needed in which the healthcare
practitioner and patient are able to see the whole algorithm to
give a sense of the treatment journey and future options with a
more focused view of the immediately relevant treatment decisions.
Healthcare practitioners felt that effective training and resources
would be central to successful implementation for e-pathways.
This replicated experience elsewhere,34 and is a timely reminder
that sufficient resources need to be allocated to training
It was notable that although the bipolar e-pathway team saw the
identification of gaps between best practice and actual practice as an
important function of the e-pathway – a way of identifying gaps in
training and provision, and of informing service development –
these gaps appeared to raise anxieties in the workshop attendees.
This will need careful consideration during the process of
e-pathway development.
e‐Pathway for bipolar disorder
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This project had several limitations. First, as this was a valuable
opportunity to have access to a task-specific group of healthcare pro-
fessionals and people with bipolar disorder, the research had to be as
pragmatic as possible. As such, only one researcher undertook data
collection and because of logistical constraints, and data from only
the most relevant focus group were transcribed. Further detail,
which may have helped to answer the research questions, may have
therefore been missed. Because of the lack of transcription, it may
have been beneficial to validate the derived transcript and arising
themes with participants; however, this was not possible within the
current study. Additionally, one researcher carried out the qualitative
analysis, which may have made it more susceptible to subjectivity.
The researcher also developed the analytical framework, and this
was discussed and refined with other members of the team.35 A
further limitation is that few people with bipolar disorder responded
to the invitation to the workshop, and therefore feedback was primar-
ily from healthcare professionals. Although clinicians will use
e-pathways in day-to-day practice, implementation will affect
patients through the care and interventions they receive. As such,
it is vital to gain an understanding of the views of patients in the
development and implementation process. Therefore, this process
would have benefitted from further contributions from people with
bipolar disorder. One patient in attendance agreed that they would
take the concept of e-pathways to their bipolar support group, with
feedback shared in a less formal setting, and their input will help to
shape the development of the pathway.
This research assessed attitudes toward a treatment pathway
that is yet to be implemented. Although it is essential to ascertain
stakeholders’ views throughout development, it is also important
to assess the system once in practice. Future research should
examine the use of e-pathways once implemented. This could
either be a quantitative assessment of the magnitude of change in
care, using outcome measures as described in studies above, such
as ratings on self-report measures and rates of hospital admission.
If the e-pathway functions correctly, it would be predicted that
patients with bipolar disorder will have lower rates of readmission
and relapse. A qualitative methodology, as used here, could
examine healthcare professionals and patients’ views (e.g. at the
onset of implementation and 1 year later), to determine whether
the perceived benefits of e-pathways are realised in practice, and if
the costs identified in the current research are sufficiently overcome.
In conclusion, the provision of e-pathway-supported,
algorithm-informed care has huge potential to inform service devel-
opment, identify training needs, enhance collaborative clinical
decision-making, streamline processes and improve quality of
care. There are considerable hurdles to overcome before the
development and subsequent delivery can occur, but an optimised
e-pathway has the potential to improve outcomes and equity for
patients with bipolar disorder.
Adele Louise Elliott, Translational and Clinical Research Institute, Newcastle University,
UK; Stuart Watson , Translational and Clinical Research Institute, Newcastle
University, UK; and North Locality, Central Business Unit, Cumbria, Northumberland, Tyne
and Wear NHS Foundation Trust, UK; Guy Dodgson, Translational and Clinical Research
Institute, Newcastle University, UK; and North Locality, Central Business Unit, Cumbria,
Northumberland, Tyne and Wear NHS Foundation Trust, UK; Esther Cohen-Tovée,
North Locality, Central Business Unit, Cumbria, Northumberland, Tyne and Wear NHS
Foundation Trust, UK; Jonathan Ling, Faculty of Health Sciences and Wellbeing,
University of Sunderland, UK
Correspondence: Stuart Watson. Email: stuart.watson@ncl.ac.uk
First received 6 Nov 2020, final revision 1 Feb 2021, accepted 7 Feb 2021
Data availability
Data available on request due to privacy/ethical restrictions.
Author contributions
A.L.E. collected, collated and analysed the data, and wrote the first draft of the manuscript and
co-ordinated input from other authors. J.L. supervised the qualitative analysis and data collec-
tion. S.W. provided overview of the project. G.D. led on the e-pathway development work and
E.C.-T. led on its application to service development. All authors contributed to study design
and write-up, and agreed the final version of the manuscript.
Funding





1 Grande I, Berk M, Birmaher B, Vieta E. Bipolar disorder. Lancet 2016; 387
(10027): 1561–72.
2 Clemente AS, Diniz BS, Nicolato R, Kapczinski FP, Soares JC, Firmo JO, et al.
Bipolar disorder prevalence: a systematic review and meta-analysis of the lit-
erature. Rev Bras Psiquiatr 2015; 37(2): 155–61.
3 American Psychiatric Association (APA). Diagnostic and Statistical Manual of
Mental Disorders (DSM-5). APA, 2013.
4 Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, Solomon DA, et al. The
long-term natural history of the weekly symptomatic status of bipolar I dis-
order. Arch Gen Psychiatry 2002; 59: 530–7.
5 Belmaker RH. Bipolar disorder. N Engl J Med 2004; 351(5): 476–86.
6 Rosa A, Franco C, Martinez-Aran A, Sanchez-Moreno J, ReinaresM, SalameroM,
et al. Functional impairment in patients with remitted bipolar disorder. Bipolar
Disord 2007; 9: 90–2.
7 Zimmerman M, Galione JN, Chelminski I, Young D, Dalrymple K, Ruggero CJ.
Sustained unemployment in psychiatric outpatients with bipolar disorder: fre-
quency and association with demographic variables and comorbid disorders.
Bipolar Disord 2010; 12(7): 720–6.
8 Tondo L, Isacsson G, Baldessarini R. Suicidal behaviour in bipolar disorder: risk
and prevention. CNS Drugs 2003; 17(7): 491–511.
9. McCrone P, Dhanasiri S, Patel A, Knapp M, Lawton-Smith S. Paying the Price:
The Cost of Mental Health Care in England to 2026. The King’s Fund, 2008.
10 YoungAH, RigneyU, Shaw S, Emmas C, Thompson JM. Annual cost ofmanaging
bipolar disorder to the UK healthcare system. J Affect Disord 2011; 133(3):
450–6.
11 Engel GL. The need for a new medical model: a challenge for biomedicine.
Science 1977; 196(4286): 129–36.
12 Goodwin G, Haddad P, Ferrier I, Aronston J, Barnes T, Cipriani A, et al. Evidence-
based guidelines for treating bipolar disorder: revised third edition recommen-
dations from the British Association for Psychopharmacology.
J Psychopharmacol 2016; 30(6): 495–553.
13 National Institute for Health and Care Excellence, National Collaborating Centre
for Mental Health. The NICE Guideline on the Assessment and Management of
Bipolar Disorder in Adults, Children and Young People in Primary and
Secondary Care Updated Edition: National Clinical Guideline Number 185. The
British Psychological Society & The Royal College of Psychiatrists, 2017 (https://
www.nice.org.uk/guidance/cg185/evidence/full-guideline-pdf-4840895629).
14 Geddes JR, Miklowitz DJ. Treatment of bipolar disorder. Lancet 2013; 381
(9878): 1672–82.
15 Vieta E. Improving treatment adherence in bipolar disorder through psychoe-
ducation. J Clin Psychiatry 2005; 66(1): 24–9.
16 Colom F, Vieta E, Martínez-Arán A, Reinares M, Goikolea JM, Benabarre A, et al.
A randomized trial on the efficacy of group psychoeducation in the prophylaxis
of recurrences in bipolar patients whose disease is in remission. Arch Gen
Psychiatry 2003; 60(4): 402–7.
17 Colom F, Vieta E, Sanchez-Moreno J, Palomino-Otiniano R, Reinares M,
Goikolea JM, et al. Group psychoeducation for stabilised bipolar disorders:
5-year outcome of a randomised clinical trial. Br J Psychiatry 2009; 194(3):
260–5.
18 Miklowitz DJ, Scott J. Psychosocial treatments for bipolar disorder: cost-effect-
iveness, mediating mechanisms, and future directions. Bipolar Disord 2009;
Suppl 2: 110–22.
19 Candini V, Buizza C, Ferrari C, CalderaMT, Ermentini R, Ghilardi A, et al. Is struc-
tured group psychoeducation for bipolar patients effective in ordinary mental
health services? A controlled trial in Italy. J Affect Disord 2013; 151(1): 149–55.
Elliott et al
6
Downloaded from https://www.cambridge.org/core. 19 Apr 2021 at 14:01:55, subject to the Cambridge Core terms of use.
20 Morriss R, Lobban F, Riste L, Davies L, Holland F, Long R, et al. Clinical effective-
ness and acceptability of structured group psychoeducation versus optimised
unstructured peer support for patients with remitted bipolar disorder
(PARADES): a pragmatic, multicentre, observer-blind, randomised controlled
superiority trial. Lancet Psychiatry 2016; 3(11): 1029–38.
21 Page R, Herbert I. Developing e-pathway standards. In e-Pathways: Computers
and the Patient’s Journey through Care (eds K de Luc, J Todd): 155–82. Radcliffe
Medical Press, 2003.
22 Gooch P, Roudsari A. Computerization of workflows, guidelines, and care
pathways: a review of implementation challenges for process-oriented health
information systems. J Am Med Inform Assoc 2011; 18(6): 738–48.
23 Green G, Defoe EC. What is a clinical algorithm? Clin Pediatr 1978; 17(5):
457–63.
24 Bauer M, Pfennig A, Linden M, Smolka MN, Neu P, Adli M. Efficacy of an
algorithm-guided treatment compared with treatment as usual: a randomized,
controlled study of inpatients with depression. J Clin Psychopharmacol 2009;
29(4): 327–33.
25 Guo T, Xiang Y-T, Xiao L, Hu C-Q, Chiu HFK, Ungvari GS, et al. Measurement-
based care versus standard care for major depression: a randomized
controlled trial with blind raters. Am J Psychiatry 2015; 172(10): 1004–13.
26 Suppes T, Swann AC, Dennehy EB, Habermacher ED, Mason M, Crismon ML,
et al. Texas Medication Algorithm Project: development and feasibility testing
of a treatment algorithm for patients with bipolar disorder. J Clin Psychiatry
2001; 62(6): 439.
27 Lima AF, Miguel SR, Cohen M, Zimmermann JJ, Shansis FM, Cruz LN, et al.
Effectiveness evaluation of mood disorder treatment algorithms in Brazilian
public healthcare patients. Rev Bras Psiquiatr 2018; 40(1): 26–34.
28 Willis CD, Saul J, Bevan H, Scheirer MA, Best A, Greenhalgh T, et al. Sustaining
organizational culture change in health systems. J Health Organ Manag 2016;
30(1): 2–30.
29 Erlingsdottir G, Ersson A, Borell J, Rydenfält C. Driving for successful change
processes in healthcare by putting staff at the wheel. J Health Organ Manag
2018; 32(1): 69–84.
30 Ritchie J, Spencer L. Qualitative data analysis for applied policy research. Qual
Res Companion 2002; 573(2002): 305–29.
31 Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework
method for the analysis of qualitative data inmulti-disciplinary health research.
BMC Med Res Methodol 2013; 13: 117.
32 Heath G, Cameron E, Cummins C, Greenfield S, Pattison H, Kelly D, et al.
Paediatric ‘care closer to home’: stake-holder views and barriers to implemen-
tation. Health Place 2012; 18(5): 1068–73.
33 Nomura S, Sawamura T, Kobayashi N, Yoshino A. Medication algorithm for
mood disorders: present status and future direction in Japan. Int J Psychiatry
Clin Practice 2004; 8(3): 139–45.
34 Grol R,WensingM.What drives change? Barriers to and incentives for achieving
evidence-based practice. Med J Aust 2004; 180: S57–60.
35 Parkinson S, Eatough V, Holmes J, Stapley E, Midgley N. Framework analysis: a
worked example of a study exploring young people’s experiences of depres-
sion. Qual Res Psychol 2016; 13(2): 109–29.
e‐Pathway for bipolar disorder
7
Downloaded from https://www.cambridge.org/core. 19 Apr 2021 at 14:01:55, subject to the Cambridge Core terms of use.
